Nifty
Sensex
:
:
23063.10
73580.54
-383.70 (-1.64%)
-1247.71 (-1.67%)

Pharmaceuticals & Drugs

Rating :
41/99

BSE: 524572 | NSE: Not Listed

29.80
24-Sep-2026
  • Open
  • High
  • Low
  • Previous Close
  •  30.78
  •  30.78
  •  29.62
  •  30.11
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  1677
  •  50492
  •  30.78
  •  0

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 105.10
  • N/A
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 125.88
  • N/A
  • 2.12

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 32.99%
  • 0.35%
  • 47.60%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 19.06%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 24.34
  • 47.90
  • 22.65

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 44.82
  • -
  • 1.76

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 13.73

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.39
  • 3.39
  • 3.39

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • -13.54
  • -13.54
  • -13.54

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
4.12
6.66
-38.14%
7.18
4.77
50.52%
5.43
4.71
15.29%
8.61
5.24
64.31%
Expenses
4.87
12.07
-59.65%
7.52
8.68
-13.36%
7.93
7.59
4.48%
13.93
7.65
82.09%
EBITDA
-0.74
-5.41
-
-0.34
-3.91
-
-2.50
-2.88
-
-5.32
-2.41
-
EBIDTM
-18.05%
-81.17%
-4.70%
-81.96%
-46.13%
-61.24%
-61.87%
-45.98%
Other Income
0.05
0.04
25.00%
0.10
0.07
42.86%
0.08
0.01
700.00%
0.22
0.01
2,100.00%
Interest
0.60
1.20
-50.00%
0.65
1.01
-35.64%
0.72
0.49
46.94%
1.08
0.34
217.65%
Depreciation
0.49
0.61
-19.67%
0.48
0.62
-22.58%
0.48
0.64
-25.00%
0.47
0.61
-22.95%
PBT
2.41
-7.17
-
-1.46
-5.40
-
-4.02
-4.01
-
-3.66
-3.27
-
Tax
0.54
-1.86
-
-0.37
-0.60
-
-1.38
-1.00
-
-1.13
-1.00
-
PAT
1.87
-5.31
-
-1.08
-4.80
-
-2.65
-3.01
-
-2.53
-2.27
-
PATM
45.40%
-79.76%
-15.09%
-100.71%
-48.73%
-64.03%
-29.40%
-43.42%
EPS
0.63
-1.40
-
-0.51
-1.12
-
-0.70
-0.55
-
-0.70
-0.55
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Net Sales
25.34
27.88
19.45
15.11
0.00
3.94
Net Sales Growth
18.52%
43.34%
28.72%
0
-100%
 
Cost Of Goods Sold
15.26
17.15
12.82
11.47
0.89
3.57
Gross Profit
10.08
10.73
6.62
3.64
-0.89
0.37
GP Margin
39.76%
38.49%
34.04%
24.09%
0
9.39%
Total Expenditure
34.25
41.39
32.19
27.49
9.89
3.80
Power & Fuel Cost
-
1.54
1.28
1.21
0.00
0.00
% Of Sales
-
5.52%
6.58%
8.01%
0
0%
Employee Cost
-
13.38
13.16
9.20
1.13
0.04
% Of Sales
-
47.99%
67.66%
60.89%
0
1.02%
Manufacturing Exp.
-
0.89
1.37
1.42
0.02
0.00
% Of Sales
-
3.19%
7.04%
9.40%
0
0%
General & Admin Exp.
-
8.29
3.35
3.21
0.80
0.18
% Of Sales
-
29.73%
17.22%
21.24%
0
4.57%
Selling & Distn. Exp.
-
0.14
0.19
0.09
0.00
0.01
% Of Sales
-
0.50%
0.98%
0.60%
0
0.25%
Miscellaneous Exp.
-
0.00
0.02
0.89
7.06
0.00
% Of Sales
-
0%
0.10%
5.89%
0
0%
EBITDA
-8.90
-13.51
-12.74
-12.38
-9.89
0.14
EBITDA Margin
-35.12%
-48.46%
-65.50%
-81.93%
0
3.55%
Other Income
0.45
0.29
0.10
0.88
0.00
0.02
Interest
3.05
3.52
2.10
1.58
0.00
0.00
Depreciation
1.92
2.03
2.44
1.72
0.02
0.01
PBT
-6.73
-18.77
-17.18
-14.80
-9.91
0.14
Tax
-2.34
-4.73
-3.77
-3.78
-2.35
0.00
Tax Rate
34.77%
29.00%
21.82%
24.20%
23.71%
0.00%
PAT
-4.39
-11.71
-10.78
-7.96
-7.56
0.15
PAT before Minority Interest
-4.56
-11.57
-13.51
-11.84
-7.56
0.15
Minority Interest
-0.17
-0.14
2.73
3.88
0.00
0.00
PAT Margin
-17.32%
-42.00%
-55.42%
-52.68%
0
3.81%
PAT Growth
0.00%
-
-
-
-
 
EPS
-1.24
-3.32
-3.05
-2.25
-2.14
0.04

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Shareholder's Funds
47.65
59.32
72.05
22.46
8.67
Share Capital
35.27
35.27
35.27
21.44
10.27
Total Reserves
12.39
24.05
36.78
0.67
-1.60
Non-Current Liabilities
3.37
25.59
2.60
-2.71
-0.36
Secured Loans
3.35
2.33
3.59
0.00
0.00
Unsecured Loans
8.49
27.85
0.00
0.00
0.00
Long Term Provisions
0.18
0.78
0.62
0.00
0.00
Current Liabilities
24.01
28.71
11.58
2.12
2.44
Trade Payables
2.78
16.32
5.12
1.88
2.31
Other Current Liabilities
12.11
7.21
5.23
0.24
0.13
Short Term Borrowings
9.07
5.06
1.15
0.00
0.00
Short Term Provisions
0.05
0.12
0.08
0.00
0.00
Total Liabilities
74.98
109.34
84.68
21.87
10.75
Net Block
53.94
76.61
63.42
0.11
0.03
Gross Block
58.96
81.24
65.78
1.18
0.51
Accumulated Depreciation
5.02
4.63
2.36
1.07
0.48
Non Current Assets
63.99
88.36
71.14
3.44
8.09
Capital Work in Progress
6.10
4.53
7.00
2.00
0.45
Non Current Investment
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Adv.
2.23
5.90
0.72
1.34
7.61
Other Non Current Assets
1.73
1.32
0.00
0.00
0.00
Current Assets
10.99
20.99
13.53
18.32
2.67
Current Investments
0.00
0.00
0.00
3.31
0.00
Inventories
0.41
12.18
3.59
0.00
0.89
Sundry Debtors
3.43
3.13
2.68
2.05
1.34
Cash & Bank
0.13
0.82
4.80
12.75
0.41
Other Current Assets
7.01
0.40
0.16
0.00
0.03
Short Term Loans & Adv.
4.16
4.45
2.30
0.20
0.03
Net Current Assets
-13.02
-7.73
1.96
16.19
0.23
Total Assets
74.98
109.35
84.67
21.88
10.76

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Cash From Operating Activity
-4.06
-15.11
-10.62
-4.02
-0.26
PBT
-16.30
-17.28
-15.62
-9.91
0.14
Adjustment
2.28
4.81
3.88
0.05
0.01
Changes in Working Capital
9.97
-2.58
1.12
5.84
-0.41
Cash after chg. in Working capital
-4.06
-15.05
-10.62
-4.02
-0.26
Interest Paid
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
-0.06
0.00
0.00
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
23.34
-12.22
-74.99
-4.94
0.47
Net Fixed Assets
13.97
-9.03
-16.93
-1.16
Net Investments
0.07
-0.01
-49.33
-3.27
Others
9.30
-3.18
-8.73
-0.51
Cash from Financing Activity
-19.97
23.36
77.66
21.31
0.00
Net Cash Inflow / Outflow
-0.69
-3.98
-7.95
12.35
0.21
Opening Cash & Equivalents
0.82
4.80
12.75
0.41
0.20
Closing Cash & Equivalent
0.13
0.82
4.80
12.75
0.41

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Book Value (Rs.)
13.51
16.82
20.43
10.26
8.44
ROA
-12.56%
-13.92%
-22.23%
-46.31%
1.35%
ROE
-21.64%
-20.56%
-25.19%
-49.28%
1.67%
ROCE
-15.67%
-17.65%
-28.16%
-63.88%
1.65%
Fixed Asset Turnover
0.40
0.26
0.45
0.00
7.75
Receivable days
42.92
54.50
57.16
0.00
124.04
Inventory Days
82.44
148.04
86.74
0.00
82.25
Payable days
203.23
305.00
111.37
861.27
235.65
Cash Conversion Cycle
-77.87
-102.46
32.53
-861.27
-29.36
Total Debt/Equity
0.44
0.59
0.07
0.00
0.00
Interest Cover
-3.63
-7.23
-8.90
-3001.33
52.27

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.